NO170331C - Analogifremgangsmaate for fremstilling av terapeutisk aktive acyleringsprodukter av bis(2-imidazolin-2-ylhydrazoner)av 9,10-antracen- dikarboksaldehyd - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive acyleringsprodukter av bis(2-imidazolin-2-ylhydrazoner)av 9,10-antracen- dikarboksaldehydInfo
- Publication number
- NO170331C NO170331C NO874404A NO874404A NO170331C NO 170331 C NO170331 C NO 170331C NO 874404 A NO874404 A NO 874404A NO 874404 A NO874404 A NO 874404A NO 170331 C NO170331 C NO 170331C
- Authority
- NO
- Norway
- Prior art keywords
- bis
- hydrazons
- antracen
- dicarboxaldehyde
- imidazoline
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- -1 2-IMIDAZOLINE-2-YL Chemical class 0.000 title 1
- 230000010933 acylation Effects 0.000 title 1
- 238000005917 acylation reaction Methods 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- SBRUFOSORMQHES-UHFFFAOYSA-N anthracene-9,10-dialdehyde Chemical compound C1=CC=C2C(C=O)=C(C=CC=C3)C3=C(C=O)C2=C1 SBRUFOSORMQHES-UHFFFAOYSA-N 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/52—Nitrogen atoms not forming part of a nitro radical with hetero atoms directly attached to said nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92222086A | 1986-10-23 | 1986-10-23 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO874404D0 NO874404D0 (no) | 1987-10-22 |
| NO874404L NO874404L (no) | 1988-04-25 |
| NO170331B NO170331B (no) | 1992-06-29 |
| NO170331C true NO170331C (no) | 1992-10-07 |
Family
ID=25446718
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO874404A NO170331C (no) | 1986-10-23 | 1987-10-22 | Analogifremgangsmaate for fremstilling av terapeutisk aktive acyleringsprodukter av bis(2-imidazolin-2-ylhydrazoner)av 9,10-antracen- dikarboksaldehyd |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0264901B1 (de) |
| JP (1) | JPS63115868A (de) |
| KR (1) | KR880005119A (de) |
| AT (1) | ATE109773T1 (de) |
| AU (1) | AU602537B2 (de) |
| CA (1) | CA1321204C (de) |
| DE (1) | DE3750358D1 (de) |
| DK (1) | DK553587A (de) |
| FI (1) | FI874653A (de) |
| HU (1) | HU206087B (de) |
| IL (1) | IL84213A (de) |
| NO (1) | NO170331C (de) |
| NZ (1) | NZ222250A (de) |
| PH (1) | PH25711A (de) |
| PT (1) | PT85982B (de) |
| ZA (1) | ZA877951B (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0338372A3 (de) * | 1988-04-22 | 1991-10-09 | American Cyanamid Company | Solubilisierte Vorstufen von Medikamenten |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3996372A (en) * | 1975-12-03 | 1976-12-07 | Shell Oil Company | Insecticidal 1-acyl-3-substituted-2-(nitro(phenylthio)-methylene)imidazolidines |
| GB2009171B (en) * | 1977-11-28 | 1982-08-18 | American Cyanamid Co | Anthracene bis-carbonyl hydrazones and derivatives |
| US4258181A (en) * | 1978-09-05 | 1981-03-24 | American Cyanamid Company | Substituted 9,10-anthracenebishydrazones |
| DE3133887A1 (de) * | 1981-08-27 | 1983-03-10 | Bayer Ag, 5090 Leverkusen | 2-arylhydrazino-2-imidazoline, deren acylderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von endo- und ektoparasiten |
-
1987
- 1987-10-19 IL IL84213A patent/IL84213A/xx not_active IP Right Cessation
- 1987-10-20 DE DE3750358T patent/DE3750358D1/de not_active Expired - Lifetime
- 1987-10-20 AT AT87115324T patent/ATE109773T1/de active
- 1987-10-20 EP EP87115324A patent/EP0264901B1/de not_active Expired - Lifetime
- 1987-10-21 CA CA000549838A patent/CA1321204C/en not_active Expired - Fee Related
- 1987-10-21 NZ NZ222250A patent/NZ222250A/en unknown
- 1987-10-22 FI FI874653A patent/FI874653A/fi not_active Application Discontinuation
- 1987-10-22 ZA ZA877951A patent/ZA877951B/xx unknown
- 1987-10-22 AU AU80033/87A patent/AU602537B2/en not_active Ceased
- 1987-10-22 DK DK553587A patent/DK553587A/da not_active Application Discontinuation
- 1987-10-22 KR KR870011805A patent/KR880005119A/ko not_active Application Discontinuation
- 1987-10-22 NO NO874404A patent/NO170331C/no unknown
- 1987-10-23 JP JP62268027A patent/JPS63115868A/ja active Pending
- 1987-10-23 HU HU874751A patent/HU206087B/hu not_active IP Right Cessation
- 1987-10-23 PT PT85982A patent/PT85982B/pt not_active IP Right Cessation
- 1987-10-23 PH PH35977A patent/PH25711A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR880005119A (ko) | 1988-06-28 |
| JPS63115868A (ja) | 1988-05-20 |
| FI874653A0 (fi) | 1987-10-22 |
| NO874404D0 (no) | 1987-10-22 |
| DE3750358D1 (de) | 1994-09-15 |
| PH25711A (en) | 1991-09-18 |
| AU8003387A (en) | 1988-04-28 |
| PT85982A (en) | 1987-11-01 |
| AU602537B2 (en) | 1990-10-18 |
| EP0264901B1 (de) | 1994-08-10 |
| DK553587A (da) | 1988-04-24 |
| HUT45505A (en) | 1988-07-28 |
| NZ222250A (en) | 1990-04-26 |
| IL84213A0 (en) | 1988-03-31 |
| FI874653A (fi) | 1988-04-24 |
| EP0264901A1 (de) | 1988-04-27 |
| ATE109773T1 (de) | 1994-08-15 |
| IL84213A (en) | 1992-09-06 |
| PT85982B (pt) | 1990-08-31 |
| ZA877951B (en) | 1988-04-26 |
| NO170331B (no) | 1992-06-29 |
| HU206087B (en) | 1992-08-28 |
| CA1321204C (en) | 1993-08-10 |
| NO874404L (no) | 1988-04-25 |
| DK553587D0 (da) | 1987-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO175620C (no) | Fremgangsmåte for fremstilling av et antitumorvirksomt legemiddel | |
| NO890259D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider. | |
| NO172389C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazoler | |
| DK336688D0 (da) | Nucleosider od fremgangsmaade til fremstilling deraf | |
| ATE65402T1 (de) | Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung. | |
| NO171412C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater | |
| NO870397L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive organiske platinakomplekser. | |
| NO171909C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater | |
| DE3764559D1 (de) | 4-benzyloxy-3-pyrrolin-2-on-1-yl-acetamid, dessen herstellung und verwendung. | |
| NO171211C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner | |
| NO170331C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive acyleringsprodukter av bis(2-imidazolin-2-ylhydrazoner)av 9,10-antracen- dikarboksaldehyd | |
| ES2129053T3 (es) | Nuevos derivados de fosfolipidos. | |
| NO890261L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater. | |
| NO870398L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive organiske platinakomplekser. | |
| GR3020597T3 (en) | Phospholipids for the treatment of multiple sclerosis | |
| NO170545C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 6,21-dimethyl-19-nor-pregna-diener | |
| NO921307D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3,5-tritianderivater | |
| NO170541C (no) | Analogiframgangsmaate for framstilling av terapeutisk aktive 1,5-benzotiazepinderivater | |
| NO170017C (no) | Analogiframgangsmaate for framstilling av terapeutisk aktive 1,5-benzotiazepinderivater |